Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-02-27
2007-02-27
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S024000, C514S025000, C536S004100, C536S017200, C536S017600, C536S018700, C536S053000, C536S054000
Reexamination Certificate
active
10482110
ABSTRACT:
Galactosylceramide analogues represented by the following formula (1) or (2).(wherein X and Y each represent S or O, R1and R2each represent an alkyl group or an alkenyl group each having 9 to 35 carbon atoms. R3represents an alkyl group or an alkenyl group each having 2 to 30 carbon atoms.)It is provided a β-glucocerebrosidase activator which is easily available, and external skin preparations and a method of activating β-glucocerebrosidase, in which improvement in formation of horny layer transmission barrier is expected by activating β-glucocerebrosidase so that an improved effect in rough skin is also expected.
REFERENCES:
patent: 5-186491 (1993-07-01), None
patent: 5-202085 (1993-08-01), None
patent: 5-202085 (1993-08-01), None
patent: 8-116971 (1996-05-01), None
patent: 8-116971 (1996-05-01), None
patent: WO 95/25736 (1995-09-01), None
patent: WO 95/25736 (1995-09-01), None
Faroux-Corlay et al., Synthesis of Single- and Double-Chain Fluorocarbon and Hydrocarbon Galactosyl Amphiphiles and their anti-HIV-1 Activity, Carbohydrate Research, vol. 327, issue 3, pp. 223-260, Jul. 2000.
Sasaki et al., “Synthesis of Novel Galactosyl Ligands for Liposomes and the Influence of the Spacer on Accumulation in the Rat Liver”, Biological and Pharmeucitical Bulletin, vol. 18, No. 5, pp. 740-746, May 1995.
P.D. Mier et al., “Lysosomal Hydrolases of the Epidermis”, British Journal of Dermatology, vol. 95, 1976, pp. 271-274.
B. Faroux-Corlay et al., “Synthesis of Single- and Double-Chain Fluorocarbon and Hydrocarbon Galactosyl Amphiphiles and their anti-HIV-1 Activity”, Carbohydrate Research, vol. 327, Issue 3, Jul. 24, 2000, pp. 223-260.
A. Sasaki et al., “Syntheses of Novel Galactosyl Ligands for Liposomes and the Influence of the Spacer on Accumulation in the Rat Liver”, Biological & Pharmaceutical Bulletin, vol. 18, No. 5. May 5, 1995, pp. 740-746.
Hara, M. et al., “Galactocerebroside and Not Glucocerebroside or Ceramide Stimulate Epidermal β-Glucocerebrosidase Activity,” Journal of Dermatological Science, Jan. 1998, vol. 16, No. 2, pp. 111-119.
Fukunaga Kyoko
Hara Mariko
Inoue Shintaro
Nakajima Fumio
Nishimura Shin-ichiro
Jiang Shaojia Anna
Kao Corporation
McIntosh III Traviss C.
LandOfFree
Galactosylceramide analogs, and β-glucocerebrosidase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galactosylceramide analogs, and β-glucocerebrosidase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galactosylceramide analogs, and β-glucocerebrosidase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3807505